Trial Profile
A double-blind, placebo-controlled, parallel-group, 12-week trial to assess the efficacy and safety of MK0663 [etoricoxib] in patients with chronic low back pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary)
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Organon
- 04 Nov 2006 New trial record.